Literature DB >> 25554368

Colchicine: old and new.

Anastasia Slobodnick1, Binita Shah2, Michael H Pillinger3, Svetlana Krasnokutsky1.   

Abstract

Although colchicine has been a focus of research, debate, and controversy for thousands of years, the US Food and Drug Administration just approved it in 2009. Over the past decade, advances in the knowledge of colchicine pharmacology, drug safety, and mechanisms of action have led to changes in colchicine dosing and to potential new uses for this very old drug. In this review, we discuss the pharmacologic properties of colchicine and summarize what is currently known about its mechanisms of action. We then discuss and update the use of colchicine in a variety of illnesses, including rheumatic and, most recently, cardiovascular diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiovascular disease; Colchicine; Gout; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 25554368      PMCID: PMC4684410          DOI: 10.1016/j.amjmed.2014.12.010

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  80 in total

1.  Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration.

Authors:  A Dogukan; F S Oymak; H Taskapan; M Güven; B Tokgoz; C Utas
Journal:  Clin Nephrol       Date:  2001-02       Impact factor: 0.975

2.  Colchicine for the treatment of recurrent Henoch-Schönlein purpura in an adult.

Authors:  D Pyne; R Mootoo; A Bhanji
Journal:  Rheumatology (Oxford)       Date:  2001-12       Impact factor: 7.580

3.  PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing.

Authors:  Lin Wang; Gulam A Manji; Jill M Grenier; Amal Al-Garawi; Sarah Merriam; Jose M Lora; Brad J Geddes; Michael Briskin; Peter S DiStefano; John Bertin
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

4.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.

Authors:  Bernhard Maisch; Petar M Seferović; Arsen D Ristić; Raimund Erbel; Reiner Rienmüller; Yehuda Adler; Witold Z Tomkowski; Gaetano Thiene; Magdi H Yacoub
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

5.  Colchicine myopathy: a vacuolar myopathy with selective type I muscle fiber involvement. An immunohistochemical and electron microscopic study of two cases.

Authors:  C Fernandez; D Figarella-Branger; P Alla; J-R Harlé; J-F Pellissier
Journal:  Acta Neuropathol       Date:  2001-12-01       Impact factor: 17.088

6.  A double-blind trial of colchicine in Behçet's syndrome.

Authors:  S Yurdakul; C Mat; Y Tüzün; Y Ozyazgan; V Hamuryudan; O Uysal; M Senocak; H Yazici
Journal:  Arthritis Rheum       Date:  2001-11

7.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

Authors:  M Centola; G Wood; D M Frucht; J Galon; M Aringer; C Farrell; D W Kingma; M E Horwitz; E Mansfield; S M Holland; J J O'Shea; H F Rosenberg; H L Malech; D L Kastner
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

8.  The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments.

Authors:  E Mansfield; J J Chae; H D Komarow; T M Brotz; D M Frucht; I Aksentijevich; D L Kastner
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

9.  The PYRIN-CARD protein ASC is an activating adaptor for caspase-1.

Authors:  Srinivasa M Srinivasula; Jean-Luc Poyet; Marjaneh Razmara; Pinaki Datta; ZhiJia Zhang; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

Review 10.  Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response.

Authors:  Dorian O Haskard; R Clive Landis
Journal:  Arthritis Res       Date:  2002-05-09
View more
  60 in total

Review 1.  Update on colchicine, 2017.

Authors:  Anastasia Slobodnick; Binita Shah; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

2.  How the flame lily synthesizes a therapeutic natural product.

Authors:  Jing-Ke Weng
Journal:  Nature       Date:  2020-08       Impact factor: 49.962

Review 3.  Colchicine: an ancient drug with novel applications.

Authors:  B Dasgeb; D Kornreich; K McGuinn; L Okon; I Brownell; D L Sackett
Journal:  Br J Dermatol       Date:  2018-01-03       Impact factor: 9.302

4.  Colchicine in the treatment of refractory aphthous ulcerations: Review of the literature and two case reports.

Authors:  Mihaela Paula Toader; Irina Mihaela Esanu; Tatiana Taranu; Madalina Mocanu; Stefan Toader
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

5.  Efficacy of colchicine in a child with relapsing bullous Henoch-Schönlein purpura.

Authors:  Slimane Allali; Sylvie Fraitag; Benjamin Terrier; Christine Bodemer; Martin Chalumeau
Journal:  Eur J Pediatr       Date:  2015-07-21       Impact factor: 3.183

Review 6.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 7.  Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.

Authors:  Aldo L Schenone; Venu Menon
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931

Review 8.  Gout and Osteoarthritis: Associations, Pathophysiology, and Therapeutic Implications.

Authors:  Chio Yokose; Meng Chen; Adey Berhanu; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

9.  Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine.

Authors:  Nihong Lu; Yongrui Yang; Honglu Liu; Xiangli Ding; Yangbing Ou; Jiawei Xia; Yingrong Du
Journal:  3 Biotech       Date:  2019-10-10       Impact factor: 2.406

Review 10.  Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.

Authors:  Safaet Alam; Md Moklesur Rahman Sarker; Sadia Afrin; Fahmida Tasnim Richi; Chao Zhao; Jin-Rong Zhou; Isa Naina Mohamed
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.